Aktienanalyse zu Moolec Science SA (MLEC)MLECMoolec Science SA

Moolec Science SA is a science-based food ingredient company. The Company operates an integrated platform encompassing research & development (R&D), manufacturing, and regulatory capabilities that span from molecular design to validation in both fermenter and field environments. It operates across the United States, Europe, and South America. The Company advances its molecular farming programs in crops such as soy and safflower to produce proteins and lipids with animal-like functionality and plant-based cost structures. It is developing a precision fermentation facility in Finland, under the SynBio Powerlabs brand, which will be dedicated to producing target proteins, enzymes, and other biomolecules using optimized microbial and cellular systems. Its product portfolio includes GLASO, PIGGY SOOY, VALORASOY, and MYCOFOOD. Its GLASO, a safflower-derived oil rich in functional lipids, is being used in formulations for small-animal feed. It operates in the Consumer Non-Cyclicals sector.

Moolec Science SA is currently a hold. The stock price is at 6.80, which is down 2.86% over the last five days, but has increased 64.25% year-to-date. However, the RSI is at 40.246, indicating potential weakness, and the gross margin is significantly negative at -25.78%, which raises concerns about profitability. The main risk is the high debt-to-equity ratio of 789.74%, suggesting financial instability.